| Dr Darra Hirsh, PHD | |
|
334 Shaw Ave Ste 100, Clovis, CA 93612 | |
| (559) 712-8500 | |
| (559) 712-8505 |
| Full Name | Dr Darra Hirsh |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 28 Years |
| Location | 334 Shaw Ave Ste 100, Clovis, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386071447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY16504 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| A Mind Above A Professional Psychology Corporation | 1759717978 | 5 |
News Archive
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer.
SearchAmerica, a part of Experian and a leader in financial clearing services for health care, today launched its newest service for hospitals, Collection Performance Advisor. The service equips hospital financial managers with a decision engine that uses advanced analytics and data to direct outstanding patient accounts to the appropriate collection team and outside agency to improve cash collections.
Mylan Inc. has announced that it and Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.
New data from a number of clinical trials presented for the first time at the International Liver Congress- 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents (DAAs) for the treatment of hepatitis C.
› Verified 2 days ago
| Entity Name | A Mind Above A Professional Psychology Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669039327 PECOS PAC ID: 1759717978 Enrollment ID: O20200207000219 |
News Archive
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer.
SearchAmerica, a part of Experian and a leader in financial clearing services for health care, today launched its newest service for hospitals, Collection Performance Advisor. The service equips hospital financial managers with a decision engine that uses advanced analytics and data to direct outstanding patient accounts to the appropriate collection team and outside agency to improve cash collections.
Mylan Inc. has announced that it and Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.
New data from a number of clinical trials presented for the first time at the International Liver Congress- 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents (DAAs) for the treatment of hepatitis C.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darra Hirsh, PHD 334 Shaw Ave Ste 100, Clovis, CA 93612-3839 Ph: (559) 712-8500 | Dr Darra Hirsh, PHD 334 Shaw Ave Ste 100, Clovis, CA 93612 Ph: (559) 712-8500 |
News Archive
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
In the U.S. and other industrialized nations, testing for infectious diseases and cancer often requires expensive equipment and highly trained specialists. In countries where resources are limited, performing the same diagnostics is far more challenging. To address this disparity, scientists are developing a portable, low-cost "paper machine" for point-of-care detection of infectious diseases, genetic conditions and cancer.
SearchAmerica, a part of Experian and a leader in financial clearing services for health care, today launched its newest service for hospitals, Collection Performance Advisor. The service equips hospital financial managers with a decision engine that uses advanced analytics and data to direct outstanding patient accounts to the appropriate collection team and outside agency to improve cash collections.
Mylan Inc. has announced that it and Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.
New data from a number of clinical trials presented for the first time at the International Liver Congress- 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents (DAAs) for the treatment of hepatitis C.
› Verified 2 days ago
Dr. Paula Jean Willis, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1920 N Burl Ave, Clovis, CA 93619 Phone: 559-274-2475 Fax: 559-325-1919 | |
Heather Pedersen, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 264 Clovis Ave # 104, Clovis, CA 93612 Phone: 559-777-9061 | |
Alexa Hilary Wasserman-toncheff, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3128 Willow, Suite 102, Clovis, CA 93612 Phone: 559-307-5814 | |
Dr. Alexia Baca Morgan, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 106 Pollasky, A, Clovis, CA 93612 Phone: 559-298-9310 Fax: 559-298-9310 | |
Dr. Randall Robinson, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 3128 Willow Ave, Suite 102, Clovis, CA 93612 Phone: 559-292-3100 Fax: 559-291-5229 | |
Dr. Kenneth John Carr, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 641 N Fowler Ave, Apt #255, Clovis, CA 93611 Phone: 209-201-2299 | |
Dr. Marvin Perez, PH.D Psychologist Medicare: Medicare Enrolled Practice Location: 2071 Herndon Ave, Clovis, CA 93611 Phone: 559-324-5574 Fax: 559-324-5575 |